Her primary areas of investigation include Virology, Antigen, Mycobacterium tuberculosis, Immunology and Vaccination. Her study in Virology is interdisciplinary in nature, drawing from both Mycobacterium bovis, Tuberculosis vaccines, Immunity, Immunogenicity and DNA vaccination. Her Antigen research incorporates elements of Spleen, Cytotoxic T cell, Antigen presentation and Microbiology.
Her Mycobacterium tuberculosis study introduces a deeper knowledge of Tuberculosis. Her is involved in several facets of Immunology study, as is seen by her studies on Immune system, BCG vaccine, Cellular immunity and Antibody. Her work is dedicated to discovering how Vaccination, Viral vector are connected with Fowlpox, Heterologous and Virus and other disciplines.
Kris Huygen mostly deals with Virology, Antigen, Immunology, Microbiology and Mycobacterium tuberculosis. Her research integrates issues of Mycobacterium bovis, Tuberculosis, Immunogenicity and DNA vaccination in her study of Virology. Her research in Antigen intersects with topics in Tuberculosis vaccines, Immune system, Spleen, Cytotoxic T cell and Antibody.
Her study in Tuberculin extends to Immunology with its themes. Her Microbiology research integrates issues from Paratuberculosis, Mycobacterium, In vitro, Interferon gamma and Mycobacterium ulcerans. Her Mycobacterium tuberculosis course of study focuses on Epitope and Molecular biology.
Kris Huygen spends much of her time researching Virology, Microbiology, Immunology, Antigen and Vaccination. Kris Huygen interconnects Epitope, Bacterial vaccine and Tuberculosis in the investigation of issues within Virology. Her biological study spans a wide range of topics, including Paratuberculosis, Mycobacterium, Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium ulcerans.
The Antibody, Immunoglobulin E and Asthma research she does as part of her general Immunology study is frequently linked to other disciplines of science, such as Comet assay, therefore creating a link between diverse domains of science. Her work deals with themes such as Cytotoxic T cell and T cell, Immune system, which intersect with Antigen. Her Tetanus, Whooping cough and Diphtheria study in the realm of Vaccination interacts with subjects such as Pertactin.
Kris Huygen focuses on Virology, Vaccination, Tuberculosis, Pertactin and Tetanus. Her Virology research is multidisciplinary, relying on both Phagosome, In vivo, Mycobacterium bovis and Microbiology. Her Vaccination study is concerned with the field of Immunology as a whole.
Her Immunology study focuses on Immune system and Antigen in particular. Her work in the fields of Mycobacterium tuberculosis and Tuberculosis vaccines overlaps with other areas such as Placebo. The various areas that Kris Huygen examines in her Mycobacterium tuberculosis study include Drug resistance and Isoquinoline.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
Huygen K;Denis O;Montgomery Dl.
Nature Medicine (1996)
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
Helen McShane;Ansar A Pathan;Clare R Sander;Sheila M Keating.
Nature Medicine (2004)
Protein Kinase G from Pathogenic Mycobacteria Promotes Survival Within Macrophages
Anne Walburger;Anil Koul;Giorgio Ferrari;Liem Nguyen.
Science (2004)
A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes.
B López;D Aguilar;H Orozco;M Burger.
Clinical and Experimental Immunology (2003)
Newborns Develop a Th1-Type Immune Response to Mycobacterium bovis Bacillus Calmette-Guérin Vaccination
Arnaud Marchant;Tessa Goetghebuer;Martin O. Ota;Ingrid Wolfe.
Journal of Immunology (1999)
Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis
Jun Wang;Lisa Thorson;Richard W. Stokes;Michael Santosuosso.
Journal of Immunology (2004)
Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis
Susan L. Baldwin;Celine D’Souza;Alan D. Roberts;Brian P. Kelly.
Infection and Immunity (1998)
Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin.
Rajesh Jayachandran;Varadharajan Sundaramurthy;Benoit Combaluzier;Philipp Mueller.
Cell (2007)
Buruli Ulcer (M. ulcerans Infection): New Insights, New Hope for Disease Control
Paul D R Johnson;Timothy P Stinear;Pamela L C Small;Gerd Pluschke.
PLOS Medicine (2005)
Improved Immunogenicity and Protective Efficacy of a Tuberculosis DNA Vaccine Encoding Ag85 by Protein Boosting
Audrey Tanghe;Sushila D'Souza;Valérie Rosseels;Olivier Denis.
Infection and Immunity (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Libre de Bruxelles
Novartis (Switzerland)
Karolinska Institute
University of Mons
University of Namur
Vrije Universiteit Brussel
London School of Hygiene & Tropical Medicine
Colorado State University
Ghent University
University of Antwerp
Delft University of Technology
University of Luxembourg
University of Geneva
Swansea University
Oak Ridge National Laboratory
University of Freiburg
University of Salamanca
Georgia Institute of Technology
University of Leicester
Utah State University
University of California, Riverside
University of Southern California
Yale University
University of Washington
Kanazawa University
Duke University